The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety between first-line therapies in metastatic castration-resistant prostate cancer in combination in the PARPi and ARSI era: A systematic review and network meta-analysis.
 
Xuanjun Guo
No Relationships to Disclose
 
Yixin Li
No Relationships to Disclose
 
Mengying Wang
Consulting or Advisory Role - Pfizer (Inst)
 
Hexiang Peng
No Relationships to Disclose
 
Huangda Guo
No Relationships to Disclose
 
Tianjiao Hou
No Relationships to Disclose
 
Hanyu Zhang
No Relationships to Disclose
 
Jin Jiang
No Relationships to Disclose
 
Tao Sheng
Employment - Pfizer
 
Yu Fan
No Relationships to Disclose
 
Tao Wu
Consulting or Advisory Role - Pfizer (Inst)
 
Zhisong He
No Relationships to Disclose